Lytix Biopharma AS

DB:6BG Stock Report

Market Cap: €25.9m

Lytix Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 6BG?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders160,3550.323%
Institutions5,938,03412%
General Public19,085,84738.5%
Private Companies24,426,06749.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.

Top Shareholders

Top 23 shareholders own 61.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.5%
Citigroup Inc.,Banking and Securities Investments
4,711,409€2.5m27.7%no data
8.93%
Jakob Hatteland Holding AS
4,428,816€2.3m47.6%no data
5.62%
Taj Holding As
2,788,900€1.5m52%no data
4.92%
Lyr Invest As
2,438,863€1.3m37.7%no data
3.75%
Waatvika As
1,860,764€972.9k0%no data
3.65%
3T Produkter Holding AS
1,808,764€945.7k0%no data
3.45%
BrøDrene Karlsen Holding A/S
1,709,274€893.7k0%no data
3.05%
Per Strand Eiendom As
1,510,769€789.9k47.5%no data
2.66%
Hifo Invest AS
1,318,913€689.6k137%no data
2.66%
Saturn Invest AS
1,318,913€689.6k137%no data
2.06%
Care Holding As
1,024,287€535.5k-15.2%no data
1.8%
Kvasshøgdi AS
890,986€465.8k47.3%no data
1.53%
Belvedere AS
760,430€397.6k33.5%no data
1.49%
Jahatt AS
738,167€385.9k47.6%no data
1.4%
Picasso AS
695,753€363.8k0%no data
1.35%
Skandinaviska Enskilda Banken AB, Asset Management Arm
669,115€349.8k0%0.05%
1.24%
Lysnes Invest As
615,654€321.9k0%no data
1.12%
Norinnova Invest AS
557,510€291.5k0%no data
1.04%
North Murray AS
516,814€270.2k0%no data
0.28%
Oystein Rekdal
139,963€73.2k0%no data
0.022%
Gjest Breistein
11,112€5.8k0%no data
0.01%
Gry Stensrud
5,000€2.6k0%no data
0.0086%
Baldur Sveinbjørnsson
4,280€2.2k0%no data